Monday, December 10, 2012 7:00:58 PM
$EKNL and DROP started the week in xtreme fashion both closing solid green – definitely keep a close watch on these plays for breakout action this week it definitely showing signs this is very close at hand.
Updated Research report will be issued this week on both DROP and EKNL
DROP jumped 10.27% today to close at its highest levels since the summer months and we expect an update on their new product that was launched online this month:
“new Drop Technology products, PowerFuse™ and ElectroFuse™ will be available online commencing December 1, 2012, at www.poweredbyfuse.com
With Tiger Woods and Arian Foster as spokemen, no doubt will have a solid impact on sales. We have seen how trigger breakout news can move stocks and last year at this time DROP soared to $1.25 when “Tiger News” hit the wires. This gave our members a potential 83,000% gains and hitting our price target dead on. We are once again looking at DROP’s current potential for solid gains – keep an eye on our research report coming this week.
EKNL continues to show brute force day after day closing a solid green session at $0.47. EKNL is definitely due for some major news to start hitting the wires to follow up from their last update:
EKO International Corp – NeuroVasc Clinical Inc. marketing updatePR Newswire(Thu Nov 15)
EKNL is definitely hinting to something major is in the works here specifically from their 13th annual medical conference attended in October
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.47 and holding solid to over 1,000% gains for close to 3 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Updated Research report will be issued this week on both DROP and EKNL
DROP jumped 10.27% today to close at its highest levels since the summer months and we expect an update on their new product that was launched online this month:
“new Drop Technology products, PowerFuse™ and ElectroFuse™ will be available online commencing December 1, 2012, at www.poweredbyfuse.com
With Tiger Woods and Arian Foster as spokemen, no doubt will have a solid impact on sales. We have seen how trigger breakout news can move stocks and last year at this time DROP soared to $1.25 when “Tiger News” hit the wires. This gave our members a potential 83,000% gains and hitting our price target dead on. We are once again looking at DROP’s current potential for solid gains – keep an eye on our research report coming this week.
EKNL continues to show brute force day after day closing a solid green session at $0.47. EKNL is definitely due for some major news to start hitting the wires to follow up from their last update:
EKO International Corp – NeuroVasc Clinical Inc. marketing updatePR Newswire(Thu Nov 15)
EKNL is definitely hinting to something major is in the works here specifically from their 13th annual medical conference attended in October
We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.
“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-international-corp-nerovasc-clinical-150600594.html
Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.
No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.
The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.
EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.
EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.
EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.
And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.
There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.47 and holding solid to over 1,000% gains for close to 3 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
